Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Core Laboratories Inc. /DE/ Director's Dealing 2024

Mar 27, 2024

32685_dirs_2024-03-27_f6e34ba5-d32e-4a9e-806e-f0084aba1eb5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2024-03-21

Reporting Person: Teo Sow Hang (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6514.334 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Shares $ Common Stock (9940) Direct

Footnotes

F1: Restricted Shares will vest in accordance with the time-based vesting schedule for each share award over a six-year period following the respective grant date. Mr. Teo has 6 awards outstanding, and of those the following number of shares remain unvested: 80 shares from the award on August 1, 2018; 350 shares from the award on May 1, 2019; 600 shares from the award on August 1, 2020; 750 shares from the award on October 1, 2020; 960 shares from the award on August 1, 2021; and 7,200 shares from the award on December 1, 2023.